Aims
We tested whethera 3D-printed cap delivers non-inferior efficiency with superior handling versus a standard commercial cap in the multicenter ENDOPRINT trial (ex vivo porcine models) which took place in Prague and Olomouc (Czech Republic) and Boston (USA).
Methods
Across three centers, 99 ESDs (33/site) were randomized 1:1 to a 3D-printed or commercial cap (Olomouc 20/13; Prague 15/18; Boston 16/17). The primary endpoint was procedure time.The secondary endpoints were lesion size, en-bloc resection rate, ergonomics, scope withdrawal for cleaning/exchange, and adverse events. The 3D-printed cap was createdon Form 3B using BioMed Flex 80A.
Results
Procedure time was the same for both caps (median 17.3 min; p=0.952); technical and en-bloc resection rates were the same (100%). Ergonomic parameters favored the 3D-printed cap (visibility 4 vs 3; manipulation 4 vs 3; retraction 5 vs 3; all p<0.001) and were replicated at each center. Adverse events were rare and similar (tears 4 vs 3; perforation 0 vs 1). Lesion size correlated with time (ρ=0.44; p=0.001), center effects, not cap type, explained time variability.
Conclusions
Custom 3D-printed distal attachment caps are non-inferior for speed and safety; however, 3D caps provide superior visibility and traction. These data support rapid, design-tailored, cost-efficient accessories for ESD and training. Clinical in vivo validation and economic analyses are warranted.